Modeling tailed bacteriophage adsorption: Insight into mechanisms

Virology

Volumn 485, Issue , 2015, Pages 355-362

  Storms, Zachary J ^a   Sauvageau, Dominic ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Adsorption efficiency; Adsorption kinetics; Phage amplification; Phage therapy; Sequential model

Indexed keywords

ADSORPTION KINETICS; ADSORPTION RATE; BACTERIOPHAGE; BINDING SITE; CELL MOTILITY; KINETIC PARAMETERS; MATHEMATICAL MODEL; MICROBIAL POPULATION DYNAMICS; NONHUMAN; PRIORITY JOURNAL; REVIEW; VIROGENESIS; VIRUS ATTACHMENT; VIRUS PARTICLE; VIRUS PLAQUE; ALGORITHM; BACTERIUM; BIOLOGICAL MODEL; KINETICS; PHYSIOLOGY; VIROLOGY;

ALGORITHMS; BACTERIA; BACTERIOPHAGES; KINETICS; MODELS, BIOLOGICAL; VIRUS ATTACHMENT;

EID: 84940859326     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2015.08.007     Document Type: Review

References (96)

1. Abedon S.T., Culler R.R. Bacteriophage evolution given spatial constraint. J. Theor. Biol. 2007, 248:111-119.
2. Adam G., Delbruck M. Reduction of dimensionality in biological diffusion processes 1968, W. H. Freeman & Company, San Francisco. A. Rich, N. Davidson (Eds.).
3. Adams M.H. Bacteriophages 1959, Wiley Interscience, New York, NY.
4. Adriaenssens E.M., Van Vaerenbergh J., Vandenheuvel D., Dunon V., Ceyssens P.J., De Proft M., Kropinski A.M., Noben J.P., Maes M., Lavigne R. T4-related bacteriophage LIMEstone isolates for the control of soft rot on potato caused by 'Dickeya solani'. Plos One 2012, 7:e33227.
5. Anderson T.F. The reactions of bacterial viruses with their host cells. Bot. Rev. 1949, 15:464-505.
6. Baptista C., Santos M.A., Sao-Jose C. Phage SPP1 reversible adsorption to Bacillus subtilis cell wall teichoic acids accelerates virus recognition of membrane receptor YueB. J. Bacteriol. 2008, 190:4989-4996.
7. Bebeacua C., Tremblay D., Farenc C., Chapot-Chartier M.P., Sadovskaya I., van Heel M., Veesler D., Moineau S., Cambillau C. Structure, adsorption to host, and infection mechanism of virulent lactococcal phage p2. J. Virol. 2013, 87:12302-12312.
8. Berg H.C., Purcell E.M. Physics of chemoreception. Biophys. J. 1977, 20:193-219.
9. Bertozzi Silva J. Bacteriophages as antimicrobial agents against bacterial contaminants in yeast fermentation processes 2013, Department of Chemical and Materials Engineering, University of Alberta, Edmonton, AB.
10. Bertozzi Silva J., Sauvageau D. Bacteriophages as antimicrobial agents against bacterial contaminants in yeast fermentation processes. Biotechnol. Biofuels 2014, 7:123.
11. Bull J.J., Vegge C.S., Schmerer M., Chaudhry W.N., Levin B.R. Phenotypic resistance and the dynamics of bacterial escape from phage control. Plos One 2014, 9:e94690.
12. Chapman-McQuiston E., Wu X.L. Stochastic receptor expression allows sensitive bacteria to evade phage attack. Part I: experiments. Biophys. J. 2008, 94:4525-4536.
13. Chapman-McQuiston E., Wu X.L. Stochastic receptor expression allows sensitive bacteria to evade phage attack. Part II: theoretical analyses. Biophys. J. 2008, 94:4537-4548.
14. Chatterjee S., Rothenberg E. Interaction of bacteriophage λ with its E. coli receptor, LamB. Viruses 2012, 4:3162-3178.
15. Chaudhry W.N., Ul Haq I., Andleeb S., Qadri I. Characterization of a virulent bacteriophage LK1 specific for Citrobacter freundii isolated from sewage water. J. Basic Microb. 2014, 54:531-541.
16. Christensen J.R. The kinetics of reversible and irreversible attachment of bacteriophage T-1. Virology 1965, 26:727-737.
17. d'Herelle F. An invisible antagonist microbe of dysentery bacillus. C.r. Acad. Sci. 1917, 165:373-375.
18. Dang X., Yi H., Ham M.H., Qi J., Yun D.S., Ladewski R., Strano M.S., Hammond P.T., Belcher A.M. Virus-templated self-assembled single-walled carbon nanotubes for highly efficient electron collection in photovoltaic devices. Nat. Nanotechnol. 2011, 6:377-384.
19. Delbruck M. Adsorption of bacteriophage under various physiological conditions of the host. J. Gen. Phys. 1940, 23:631-642.
20. Dickerson T.J., Kaufmann G.F., Janda K.D. Bacteriophage-mediated protein delivery into the central nervous system and its application in immunopharmacotherapy. Expert Opin. Biol. Ther. 2005, 5:773-781.
21. Fox J.L. Phage treatments yield healthier tomato, pepper plants. ASM News 2000, 66:455-456.
22. Fujiwara A., Fujisawa M., Hamasaki R., Kawasaki T., Fujie M., Yamada T. Biocontrol of Ralstonia solanacearum by treatment with lytic bacteriophages. Appl. Environ. Microbiol. 2011, 77:4155-4162.
23. Gallet R., Lenormand T., Wang I.N. Phenotypic stochasticity protects lytic bacteriophage populations from extinction during the bacterial stationary phase. Evolution 2012, 66:3485-3494.
24. Garen A. Thermodynamic and kinetic studies on the attachment of T1 bacteriophage to bacteria. Biochim. Biophys. Acta 1954, 14:163-172.
25. Garen A., Puck T.T. The 1st 2 steps of the invasion of host cells by bacterial viruses. II. J. Exp. Med. 1951, 94:177-189.
26. Goldberg E.B., Grinius L., Letellier L. Attachment and injection 1994, 347-348. American Society for Microbiology, Washington, DC. J.D. Karam (Ed.).
27. Golec P., Karczewska-Golec J., Los M., Wezgrzyn G. Bacteriophage T4 can produce progeny virions in extremely slowly growing Escherichia coli host: comparison of a mathematical model with the experimental data. FEMS Microbiol. Lett. 2014, 351:156-161.
28. Guenther S., Herzig O., Fieseler L., Klumpp J., Loessner M.J. Biocontrol of Salmonella Typhimurium in RTE foods with the virulent bacteriophage FO1-E2. Int. J. Food Microbiol. 2012, 154:66-72.
29. Guerrero-Ferreira R.C., Viollier P.H., Ely B., Poindexter J.S., Georgieva M., Jensen G.J., Wright E.R. Alternative mechanism for bacteriophage adsorption to the motile bacterium Caulobacter crescentus. PNAS 2011, 108:9963-9968.
30. Guntupalli R., Sorokulova I., Olsen E., Globa L., Pustovyy O., Moore T., Chin B., Barbaree J., Vodyanoy V. Detection and identification of methicillin resistant and sensitive strains of Staphylococcus aureus using tandem measurements. J. Microbiol. Methods 2012, 90:182-191.
31. Haberer K., Maniloff J. Adsorption of the tailed mycoplasma virus L3 to cell membranes. J. Virol. 1982, 41:501-507.
32. Hadas H., Einav M., Fishov I., Zaritsky A. Bacteriophage T4 development depends on the physiology of its host Escherichia coli. Microbiology 1997, 143(Pt 1):179-185.
33. Harper D.R., McConville M., Anderson F.J., Enright M.C. Antimicrobial phages 2014, Academic Press, Waltham, MA. Y.W. Tang, M. Sussman, D. Liu, I. Poxton, J. Schwartxman (Eds.).
34. Hendrix R.W., Duda R.L. Bacteriophage lambda PaPa: not the mother of all lambda phages. Science 1992, 258:1145-1148.
35. Hu B., Margolin W., Molineux I.J., Liu J. The bacteriophage T7 virion undergoes extensive structural remodeling during infection. Science 2013, 339:576-579.
36. Huang S., Yang H., Lakshmanan R.S., Johnson M.L., Chen I., Wan J., Wikle H.C., Petrenko V.A., Barbaree J.M., Cheng Z.Y., Chin B.A. The effect of salt and phage concentrations on the binding sensitivity of magnetoelastic biosensors for Bacillus anthracis detection. Biotechnol. Bioeng. 2008, 101:1014-1021.
37. Jones J.B., Jackson L.E., Balogh B., Obradovic A., Iriarte F.B., Momol M.T. Bacteriophages for plant disease control. Annu. Rev. Phytopathol. 2007, 45:245-262.
38. Kellenberger E., Bolle A., Boydelatour E., Epstein R.H., Franklin N.C., Jerne N.K., Reale Scafati A., Sechaud J. Functions and properties related to the tail fibers of bacteriophage T4. Virology 1965, 26:419-440.
39. Koch A.L. Growth of viral plaques during enlargement phase. J. Theor. Biol. 1964, 6:413.
40. Krone S.M., Abedon S.T. Modeling phage plaque growth 2008, Cambridge University Press, Cambridge, U. K. S.T. Abedon (Ed.).
41. Krueger A.P. The sorption of bacteriophage by living and dead susceptible bacteria: I. equilibrium conditions. J. Gen. Physiol. 1931, 14:493-516.
42. Lee T.J., Schwartz C., Guo P. Construction of bacteriophage phi29 DNA packaging motor and its applications in nanotechnology and therapy. Ann. Biomed. Eng. 2009, 37:2064-2081.
43. Levin B.R., Bull J.J. Phage therapy revisited: the population biology of a bacterial infection and its treatment with bacteriophage and antibiotics. Am. Nat. 1996, 147:881-898.
44. Levin B.R., Moineau S., Bushman M., Barrangou R. The population and evolutionary dynamics of phage and bacteria with CRISPR-mediated immunity. PLoS Genet. 2013, 9:e1003312.
45. Levin B.R., Stewart F.M., Chao L. Resource-limited growth, competition, and predation: a model and experimental studies with bacteria and bacteriophage. Am. Nat. 1977, 111:3-24.
46. Loessner M.J., Rees C.E.D., Stewart G.S.A.B., Scherer S. Construction of luciferase reporter bacteriophage A511::luxAB for rapid and sensitive detection of viable Listeria cells. Appl. Environ. Microbiol. 1996, 62:1133-1140.
47. Loc Carrillo C., Atterbury R., El-Shibiny A., Connerton P., Dillon E., Scott A., Connerton I. Bacteriophage therapy to reduce Campylobacter jejuni colonization of broiler chickens. Appl. Environ. Microbiol. 2005, 71:6554-6563.
48. Merabishvili M., Pirnay J.P., Verbeken G., Chanishvili N., Tediashvili M., Lashkhi N., Glonti T., Krylov V., Mast J., Van Parys L., Lavigne R., Volckaert G., Mattheus W., Verween G., De Corte P., Rose T., Jennes S., Zizi M., De Vos D., Vaneechoutte M. Quality-controlled small-scale production of a well-defined bacteriophage cocktail for use in human clinical trials. Plos One 2009, 4:e4944. 10.1371/journal.pone.0004944.
49. Moldovan R., Chapman-McQuiston E., Wu X.L. On kinetics of phage adsorption. Biophys. J. 2007, 93:303-315.
50. Monk A.B., Rees C.D., Barrow P., Hagens S., Harper D.R. Bacteriophage applications: where are we now?. Lett. Appl. Microbiol. 2010, 51:363-369.
51. Ortega-Cejas V., Fort J., Mendez V., Campos D. Approximate solution to the speed of spreading viruses. Phys. Rev. E 2004, 69:031909.
52. Park S.C., Nakai T. Bacteriophage control of Pseudomonas plecoglossicida infection in ayu Plecoglossus altivelis. Dis. Aquat. Org. 2003, 53:33-39.
53. Payne R.J., Jansen V.A. Understanding bacteriophage therapy as a density-dependent kinetic process. J. Theor. Biol. 2001, 208:37-48.
54. Petrenko V., Smith G.P. Phage Nanobiotechnology 2011, Royal Society of Chemistry Publishing, Cambridge, U.K.
55. Pirnay J.P., De Vos D., Verbeken G., Merabishvili M., Chanishvili N., Vaneechoutte M., Zizi M., Laire G., Lavigne R., Huys I., Van den Mooter G., Buckling A., Debarbieux L., Pouillot F., Azeredo J., Kutter E., Dublanchet A., Gorski A., Adamia R. The phage therapy paradigm: pret-a-porter or sur-mesure?. Pharm. Res. 2011, 28:934-937.
56. Pirnay J.P., Verbeken G., Rose T., Jennes S., Zizi M., Huys I., Lavigne R., Merabishvili M., Vaneechoutte M., Buckling A., De Vos D. Introducing yesterday's phage therapy in today's medicine. Future Virol. 2012, 7:379-390.
57. Plaut R.D., Beaber J.W., Zemansky J., Kaur A.P., George M., Biswas B., Henry M., Bishop-Lilly K.A., Mokashi V., Hannah R.M., Pope R.K., Read T.D., Stibitz S., Calendar R., Sozhamannan S. Genetic evidence for the involvement of the S-layer protein gene sap and the sporulation genes spo0A, spo0B, and spo0F in phage AP50c infection of Bacillus anthracis. J. Bacteriol. 2014, 196:1143-1154.
58. Ptashne M. A Genetic Switch: Phage Lambda Revisited 2004, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
59. Puck T.T. The first steps of virus invasion. Cold Spring Harb. Symp. Quant. Biol. 1953, 18:149-154.
60. Puck T.T., Garen A., Cline J. The mechanism of virus attachment to host cells. I. The role of ions in the primary reaction. J. Exp. Med. 1951, 93:65-88.
61. Rakhuba D.V., Kolomiets E.I., Dey E.S., Novik G.I. Bacteriophage receptors, mechanisms of phage adsorption and penetration into host cell. Pol. J. Microbiol. 2010, 59:145-155.
62. Rhoads D.D., Wolcott B.M., Kuskowski M.A., Wolcott B.M., Ward L.S., Sulakvelidze A. Bacteriophage therapy of venous leg ulcers in humans: results of a phase I safety trial. J. Wound Care 2009, 18. 237-238, 240-243.
63. Rothenberg E., Sepulveda L.A., Skinner S.O., Zeng L., Selvin P.R., Golding I. Single-virus tracking reveals a spatial receptor-dependent search mechanism. Biophys. J. 2011, 100:2875-2882.
64. Santos S.B., Carvalho C., Azeredo J., Ferreira E.C. Population dynamics of a Salmonella lytic phage and its host: implications of the host bacterial growth rate in modelling. Plos One 2014, 9:e102507. 10.1371/journal.pone.0102507.
65. Sauvageau D., Cooper D.G. Two-stage, self-cycling process for the production of bacteriophages. Microb. Cell Fact. 2010, 9:81.
66. Schlesinger M. Über die bindung des bakteriophagen an homologe bakterien. Z. Hyg. Infektionskrankheiten 1932, 114:136-148.
67. Schnabel E.L., Jones A.L. Isolation and characterization of five Erwinia amylovora bacteriophages and assessment of phage resistance in strains of Erwinia amylovora. Appl. Environ. Microbiol. 2001, 67:59-64.
68. Schofield D.a., Molineux I.J., Westwater C. Diagnostic bioluminescent phage for detection of Yersinia pestis. J. Clin. Microbiol. 2009, 47:3887-3894.
69. Schwartz M. Adsorption of coliphage lambda to its host - effect of variations in surface density of receptor and in phage-receptor affinity. J. Mol. Biol. 1976, 103:521-536.
70. Spinelli S., Veesler D., Bebeacua C., Cambillau C. Structures and host-adhesion mechanisms of lactococcal siphophages. Front. Microbiol. 2014, 5:3.
71. Steensma H.Y. Adsorption of the defective phage PBS Z1 to Bacillus subtilis 168 Wt. J. Gen. Virol. 1981, 52:93-101.
72. Steensma H.Y. An evaluation of the rate constants for the adsorption of the defective phage PBS Z to Bacillus subtilis. Antonie van Leeuwenhoek 1982, 48:183-188.
73. Stent G.S., Wollman E.L. On the 2-step nature of bacteriophage adsorption. Biochim. Biophys. Acta 1952, 8:260-269.
74. Stopar D., Abedon S.T. Modeling bacteriophage population growth 2008, Cambridge University Press, Cambridge, U. K. S.T. Abedon (Ed.).
75. Storms Z.J., Arsenault E., Sauvageau D., Cooper D.G. Bacteriophage adsorption efficiency and its effect on amplification. Bioprocess Biosyst. Eng. 2010, 33:823-831.
76. Storms Z.J., Brown T., Cooper D.G., Sauvageau D., Leask R.L. Impact of the cell life-cycle on bacteriophage T4 infection. FEMS Microbiol. Lett. 2014, 353:63-68.
77. Storms Z.J., Sauvageau D. Evidence that the heterogeneity of a T4 population is the result of heritable traits. Plos One 2014, 9:e116235.
78. Storms Z.J., Smith L., Sauvageau D., Cooper D.G. Modeling bacteriophage attachment using adsorption efficiency. Biochem. Eng. J. 2012, 64:22-29.
79. Sulakvelidze A., Alavidze Z., Morris J.G. Bacteriophage therapy. Antimicrob. Agents Chemother. 2001, 45:649-659.
80. Tao P., Mahalingam M., Kirtley M.L., van Lier C.J., Sha J., Yeager L.A., Chopra A.K., Rao V.B. Mutated and bacteriophage T4 nanoparticle arrayed F1-V immunogens from Yersinia pestis as next generation plague vaccines. PLoS Pathog. 2013, 9:e1003495.
81. Tao P., Mahalingam M., Marasa B.S., Zhang Z., Chopra A.K., Rao V.B. In vitro and in vivo delivery of genes and proteins using the bacteriophage T4 DNA packaging machine. PNAS 2013, 110:5846-5851.
82. Tawil N., Sacher E., Mandeville R., Meunier M. Surface plasmon resonance detection of E. coli and methicillin-resistant S. aureus using bacteriophages. Biosens. Bioelectron. 2012, 37:24-29.
83. Twort F.W. An investigation on the nature of ultra-microscopic viruses. Lancet 1915, 2:1241-1243.
84. Vandersteegen K., Kropinski A.M., Nash J.H.E., Noben J.P., Hermans K., Lavigne R. Romulus and Remus, two phage isolates representing a distinct clade within the Twortlikevirus genus, display suitable properties for phage therapy applications. J. Virol. 2013, 87:3237-3247.
85. Verbeken G., Pirnay J.P., De Vos D., Jennes S., Zizi M., Lavigne R., Casteels M., Huys I. Optimizing the European regulatory framework for sustainable bacteriophage therapy in human medicine. Arch. Immunol. Ther. Exp. (Warsz) 2012, 60:161-172.
86. von Smoluchowski M. Z. Phys. Chem. 1917, 92:129.
87. Watanabe H., Takesue S., Ishibashi K., Nakahara S. A computer simulation of the adsorption of Lactobacillus phage PL-1 to host cells: some factors affecting the process. Agric. Biol. Chem. 1982, 46:697-702.
88. Weitz J.S., Dushoff J. Alternative stable states in host-phage dynamics. Theor. Ecol. 2008, 1:13-19.
89. Weld R.J., Butts C., Heinemann J.A. Models of phage growth and their applicability to phage therapy. J. Theor. Biol. 2004, 227:1-11.
90. Wong C.L., Sieo C.C., Tan W.S., Abdullah N., Hair-Bejo M., Abu J., Ho Y.W. Evaluation of a lytic bacteriophage, ϕst1, for biocontrol of Salmonella enterica serovar Typhimurium in chickens. Int. J. Food Microbiol. 2014, 172:92-101.
91. Worley-Morse T.O., Deshusses M.A., Gunsch C.K. Reduction of invasive bacteria in ethanol fermentations using bacteriophages. Biotechnol. Bioeng. 2015, 112:1544-1553.
92. Wright A., Hawkins C.H., Anggard E.E., Harper D.R. A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa; a preliminary report of efficacy. Clin. Otolaryngol. 2009, 34:349-357.
93. Yin J., McCaskill J.S. Replication of viruses in a growing plaque: a reaction-diffusion model. Biophys. J. 1992, 61:1540-1549.
94. You L., Yin J. Amplification and spread of viruses in a growing plaque. J. Theor. Biol. 1999, 200:365-373.
95. Zarybnicky V., Reich M., Wolf G. A mathematical model for the reversible for the reversible two-step interaction betweent the T5 phage and its receptor in vitro. FEMS Microbiol. Lett. 1980, 7:29-33.
96. Zonenstein Y., Zaritsky A., Merchuk J., Einav M., Enden G. The initial adsorption of T4 bacteriophages to Escherichia coli cells at equivalent concentrations: experiments and mathematical modeling. Biochem. Eng. J. 2010, 48:225-229.